4.7 Review

The Function and Therapeutic Implications of TNF Signaling in MDSCs

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

TNFα antagonist in combination with PD-1 blocker to prevent or retard malignant transformation of B[a]P-induced chronic lung inflammation

Ai Zhao et al.

Summary: The study reveals the role of myeloid-derived suppressor cells (MDSCs) in the development of B[a]P-induced chronic lung inflammation and the efficacy of immunotherapy in preventing malignant transformation. TNFalpha antagonist alone or with PD-1 blocker can prevent or retard the malignant transformation of B[a]P-induced chronic lung inflammation, especially in the early stage.

CARCINOGENESIS (2022)

Article Cell Biology

Myeloid-derived suppressor cells as cellular immunotherapy in transplantation and autoimmune diseases

Jilu Zhang et al.

Summary: Myeloid-derived suppressor cells (MDSCs) play a crucial role in tumor immunity, transplantation, and autoimmune diseases due to their immunosuppressive capacity, making MDSC-based cellular therapy a promising strategy for immune related disorders.

CELLULAR IMMUNOLOGY (2021)

Article Pharmacology & Pharmacy

Exploring pharmacogenetic variants for predicting response to anti-TNF therapy in autoimmune diseases: a meta-analysis

Charalabos Antonatos et al.

Summary: The study explored how SNPs may affect the response to anti-TNF-alpha therapy in major autoimmune diseases, but no common pharmacogenetic variant was identified for all diseases studied, suggesting the need for more research to identify predictive variants for treatment selection.

PHARMACOGENOMICS (2021)

Review Biochemistry & Molecular Biology

Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer

Kai Li et al.

Summary: MDSCs are a group of immunosuppressive cells that play a crucial role in tumor progression, affecting tumor development through various pathways and interfering with the efficacy of current anti-tumor therapies. Targeting MDSCs is a promising strategy for future cancer treatment.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Article Biochemistry & Molecular Biology

Reprogramming immunosuppressive myeloid cells by activated T cells promotes the response to anti-PD-1 therapy in colorectal cancer

Jing Chen et al.

Summary: In this study, it was found that reshaping MDSCs through autocrine IFN-alpha/beta and TNF-alpha from activated T cells is crucial for successful anti-PD-1 treatment in colorectal cancer. This offers a novel strategy for improving the response and efficacy of anticancer therapy.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Review Oncology

Antibody therapeutics and immunoregulation in cancer and autoimmune disease

Masahiro Yasunaga

SEMINARS IN CANCER BIOLOGY (2020)

Correction Biochemistry & Molecular Biology

Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity Threshold (vol 178, 585.e1, 2019)

David W. Vredevoogd et al.

Article Cell & Tissue Engineering

TNFα/TNFR2 signaling pathway: an active immune checkpoint for mesenchymal stem cell immunoregulatory function

Ghada Beldi et al.

STEM CELL RESEARCH & THERAPY (2020)

Editorial Material Pharmacology & Pharmacy

MDSC; the Most Important Cell You Have Never Heard Of

R. J. Tesi

TRENDS IN PHARMACOLOGICAL SCIENCES (2019)

Article Multidisciplinary Sciences

Sexual dimorphism and the role of estrogen in the immune microenvironment of liver metastases

Simon Milette et al.

NATURE COMMUNICATIONS (2019)

Article Cardiac & Cardiovascular Systems

Cardioprotective Role of Myeloid-Derived Suppressor Cells in Heart Failure

Ling Zhou et al.

CIRCULATION (2018)

Article Geriatrics & Gerontology

Immunity and Inflammation: From Jekyll to Hyde

Weili Xu et al.

EXPERIMENTAL GERONTOLOGY (2018)

Review Immunology

Myeloid-derived suppressor cells coming of age

Filippo Veglia et al.

NATURE IMMUNOLOGY (2018)

Review Immunology

Tumor Necrosis Factor α and Regulatory T Cells in Oncoimmunology

Benoit L. Salomon et al.

FRONTIERS IN IMMUNOLOGY (2018)

Review Immunology

The Yin and Yang of Myeloid Derived Suppressor Cells

Snehil Budhwar et al.

FRONTIERS IN IMMUNOLOGY (2018)

Article Oncology

Myeloid-Derived Suppressor Cells

Dmitry I. Gabrilovich

CANCER IMMUNOLOGY RESEARCH (2017)

Article Oncology

Inhibition of Soluble Tumor Necrosis Factor Prevents Chemically Induced Carcinogenesis in Mice

Andrea Sobo-Vujanovic et al.

CANCER IMMUNOLOGY RESEARCH (2016)

Article Immunology

TnF neutralization results in the Delay of Transplantable Tumor growth and reduced MDsc accumulation

Kamar-Sulu N. Atretkhany et al.

FRONTIERS IN IMMUNOLOGY (2016)

Article Biochemistry & Molecular Biology

17β-estradiol contributes to the accumulation of myeloid-derived suppressor cells in blood by promoting TNF-α secretion

Guanjun Dong et al.

ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2015)

Review Biotechnology & Applied Microbiology

Clinically feasible approaches to potentiating cancer cell-based immunotherapies

V. I. Seledtsov et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)

Review Cell Biology

Regulated necrosis: the expanding network of non-apoptotic cell death pathways

Tom Vanden Berghe et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)

Article Immunology

Myeloid suppressor cells require membrane TNFR2 expression for suppressive activity

Johannes Polz et al.

IMMUNITY INFLAMMATION AND DISEASE (2014)

Article Cell Biology

Blood CD33(+)HLA-DR(-) myeloid-derived suppressor cells are increased with age and a history of cancer

Chris P. Verschoor et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2013)

Article Medicine, Research & Experimental

TNF signaling drives myeloid-derived suppressor cell accumulation

Xueqiang Zhao et al.

JOURNAL OF CLINICAL INVESTIGATION (2012)

Review Rheumatology

Transmembrane TNF-α: structure, function and interaction with anti-TNF agents

Takahiko Horiuchi et al.

RHEUMATOLOGY (2010)

Review Immunology

Myeloid-derived suppressor cells as regulators of the immune system

Dmitry I. Gabrilovich et al.

NATURE REVIEWS IMMUNOLOGY (2009)

Review Chemistry, Multidisciplinary

Tumor necrosis factor and cancer, buddies or foes?

Xia Wang et al.

ACTA PHARMACOLOGICA SINICA (2008)

Review Oncology

TNF-mediated inflammatory disease

J. R. Bradley

JOURNAL OF PATHOLOGY (2008)

Review Oncology

TNF-alpha in promotion and progression of cancer

Frances Balkwill

CANCER AND METASTASIS REVIEWS (2006)

Review Oncology

Paradoxical roles of the immune system during cancer development

KE de Visser et al.

NATURE REVIEWS CANCER (2006)

Review Immunology

Signalling pathways of the TNF superfamily: A double-edged sword

BB Aggarwal

NATURE REVIEWS IMMUNOLOGY (2003)

Review Cell Biology

Signal transduction by tumor necrosis factor and its relatives

V Baud et al.

TRENDS IN CELL BIOLOGY (2001)